261 related articles for article (PubMed ID: 15977040)
1. Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria.
Ikeda K; Schiltz E; Fujii T; Takahashi M; Mitsui K; Kodera Y; Matsushima A; Inada Y; Schulz GE; Nishimura H
Amino Acids; 2005 Nov; 29(3):283-7. PubMed ID: 15977040
[TBL] [Abstract][Full Text] [Related]
2. Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria.
Gámez A; Sarkissian CN; Wang L; Kim W; Straub M; Patch MG; Chen L; Striepeke S; Fitzpatrick P; Lemontt JF; O'Neill C; Scriver CR; Stevens RC
Mol Ther; 2005 Jun; 11(6):986-9. PubMed ID: 15922970
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
Sarkissian CN; Gámez A
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
[TBL] [Abstract][Full Text] [Related]
4. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.
Bell SM; Wendt DJ; Zhang Y; Taylor TW; Long S; Tsuruda L; Zhao B; Laipis P; Fitzpatrick PA
PLoS One; 2017; 12(3):e0173269. PubMed ID: 28282402
[TBL] [Abstract][Full Text] [Related]
5. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria.
Wang L; Gamez A; Sarkissian CN; Straub M; Patch MG; Han GW; Striepeke S; Fitzpatrick P; Scriver CR; Stevens RC
Mol Genet Metab; 2005; 86(1-2):134-40. PubMed ID: 16006165
[TBL] [Abstract][Full Text] [Related]
6. Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial.
Longo N; Harding CO; Burton BK; Grange DK; Vockley J; Wasserstein M; Rice GM; Dorenbaum A; Neuenburg JK; Musson DG; Gu Z; Sile S
Lancet; 2014 Jul; 384(9937):37-44. PubMed ID: 24743000
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report.
Safos S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(6):681-92. PubMed ID: 8556141
[TBL] [Abstract][Full Text] [Related]
8. [Expression in Lactococcus lactis of catalytically active phenylalanine ammonia-lyase from parsley].
Xiang H; Liu J; Hu W; Zhu J; Zhu Z
Wei Sheng Wu Xue Bao; 1999 Jun; 39(3):196-204. PubMed ID: 12555534
[TBL] [Abstract][Full Text] [Related]
9. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N
Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pah(enu2) mice.
Rossi L; Pierigè F; Carducci C; Gabucci C; Pascucci T; Canonico B; Bell SM; Fitzpatrick PA; Leuzzi V; Magnani M
J Control Release; 2014 Nov; 194():37-44. PubMed ID: 25151978
[TBL] [Abstract][Full Text] [Related]
11. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
[TBL] [Abstract][Full Text] [Related]
12. Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria.
Levy HL; Sarkissian CN; Scriver CR
Mol Genet Metab; 2018 Aug; 124(4):223-229. PubMed ID: 29941359
[TBL] [Abstract][Full Text] [Related]
13. Preservation of high phenylalanine ammonia lyase activities in roots of Japanese Striped corn: a potential oral therapeutic to treat phenylketonuria.
López-Villalobos A; Lücker J; López-Quiróz AA; Yeung EC; Palma K; Kermode AR
Cryobiology; 2014 Jun; 68(3):436-45. PubMed ID: 24657198
[TBL] [Abstract][Full Text] [Related]
14. Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria.
Gámez A; Wang L; Sarkissian CN; Wendt D; Fitzpatrick P; Lemontt JF; Scriver CR; Stevens RC
Mol Genet Metab; 2007 Aug; 91(4):325-34. PubMed ID: 17560821
[TBL] [Abstract][Full Text] [Related]
15. Biochemical analysis of Centaurea depressa phenylalanine ammonia lyase (PAL) for biotechnological applications in phenylketonuria (PKU).
Babaoğlu Aydaş S; Şirin S; Aslim B
Pharm Biol; 2016 Dec; 54(12):2838-2844. PubMed ID: 27246528
[TBL] [Abstract][Full Text] [Related]
16. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
[TBL] [Abstract][Full Text] [Related]
17. Trends in enzyme therapy for phenylketonuria.
Kim W; Erlandsen H; Surendran S; Stevens RC; Gamez A; Michols-Matalon K; Tyring SK; Matalon R
Mol Ther; 2004 Aug; 10(2):220-4. PubMed ID: 15294168
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.
Sarkissian CN; Kang TS; Gámez A; Scriver CR; Stevens RC
Mol Genet Metab; 2011 Nov; 104(3):249-54. PubMed ID: 21803624
[TBL] [Abstract][Full Text] [Related]
19. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
Ding Z; Georgiev P; Thöny B
Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
[TBL] [Abstract][Full Text] [Related]
20. Study on a novel strategy to treatment of phenylketonuria.
Liu J; Jia X; Zhang J; Xiang H; Hu W; Zhou Y
Artif Cells Blood Substit Immobil Biotechnol; 2002 Jul; 30(4):243-57. PubMed ID: 12227645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
